Halozyme Therapeutics
HALO
#2100
Rank
C$9.92 B
Marketcap
$80.33
Share price
1.61%
Change (1 day)
51.47%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2024 : C$2.07 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is C$2.07 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2024-12-31C$2.16 B8.66%
2023-12-31C$1.98 B-2.7%
2022-12-31C$2.04 B82.92%
2021-12-31C$1.11 B120.59%
2020-12-31C$0.50 B-3.67%
2019-12-31C$0.52 B205.42%
2018-12-31C$0.17 B-32.33%
2017-12-31C$0.25 B-12.61%
2016-12-31C$0.29 B321.11%
2015-12-31C$69.12 M19.47%
2014-12-31C$57.86 M9.21%
2013-12-31C$52.98 M71.26%
2012-12-31C$30.93 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$65.82 M-96.83%๐Ÿ‡บ๐Ÿ‡ธ USA
C$46.42 B 2,134.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.55 B 793.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$87.83 B 4,126.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.71 B 1,137.44%๐Ÿ‡ซ๐Ÿ‡ท France
C$50.55 B 2,332.86%๐Ÿ‡บ๐Ÿ‡ธ USA